ORYZON GENOMICS, S.A. «12345...» Page 2 out of 12 18/06/2024 11:55 ORYZON GENOMICS, S.A. Other relevant information Ampliación de capital por conversión de Obligaciones Register number: 29188 14/06/2024 09:01 ORYZON GENOMICS, S.A. Other relevant information ORYZON presents preliminary data from the ongoing FRIDA trial with iadademstat plus gilteritinib in relapsed/refractory FLT3-mut acute myeloid leukemia at the European Hematology Association congress, EHA-2024. Register number: 29142 29/05/2024 08:05 ORYZON GENOMICS, S.A. Other relevant information ORYZON selected as Associated Partner in the first Important Project of Common European Interest (IPCEI) in the health sector (Med4Cure project) Register number: 28877 27/05/2024 11:09 ORYZON GENOMICS, S.A. Announcement of general shareholders’ meeting Announcements and agreements of shareholders general meetings Register number: 28837 17/05/2024 18:58 ORYZON GENOMICS, S.A. Other relevant information La sociedad comunica la conversión de obligaciones convertibles Register number: 28726 06/05/2024 17:25 ORYZON GENOMICS, S.A. Other relevant information La Sociedad remite información sobre los resultados del primer trimestre de 2024 Register number: 28454 26/02/2024 19:23 ORYZON GENOMICS, S.A. Annual financial reports and audit reports La sociedad remite el Informe Financiero Anual del ejercicio 2023 Register number: 26757 26/02/2024 19:05 ORYZON GENOMICS, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del segundo semestre de 2023 Register number: 26755 26/02/2024 17:39 ORYZON GENOMICS, S.A. Annual report on directors´ remunerations La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2023 Register number: 26752 26/02/2024 17:31 ORYZON GENOMICS, S.A. Annual corporate governance report La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2023 Register number: 26751 Page 2 out of 12 «12345...»